1. MET-Amplified Intramucosal Gastric Cancer Widely Metastatic after Complete Endoscopic Submucosal Dissection
   Dakeun Lee et al, 1970, Cancer Research and Treatment CrossRef
2. PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer
   Kui-Jin Kim et al, 2020, Scientific Reports CrossRef
3. Case Report: Prompt Response to Savolitinib in a Case of Advanced Gastric Cancer With Bone Marrow Invasion and MET Abnormalities
   Wen Ye et al, 2022, Frontiers in Oncology CrossRef
4. MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
   Jihoon Ko et al, 2022, Pathology and Oncology Research CrossRef
5. Clinical management of advanced gastric cancer: The role of new molecular drugs
   Ferdinando De Vita, 2014, World Journal of Gastroenterology CrossRef
6. Targeted therapies in gastric cancer treatment: where we are and where we are going
   Gianluca Tomasello et al, 2016, Investigational New Drugs CrossRef
7. Gastric Cancer Pathology and Underlying Molecular Mechanisms
   Heike I. Grabsch et al, 2013, Digestive Surgery CrossRef
8. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer
   Nicola Carlomagno et al, 2017, BioMed Research International CrossRef
9. Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a validation study
   Dita Ulase et al, 2024, Virchows Archiv CrossRef